Table 3 Clinical and Cognitive Outcomes of the Subset of Participants with Follow-up (n = 54)a
From: Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
Baseline | Follow-up | p-value | |
|---|---|---|---|
CD4+ T-lymphocyte (cells/μL) | 248 (46–355) | 468 (261–673) | < 0.001 |
On cART with CPE > 7, n (%) | – | 7 (13) | – |
HIV-1 RNA suppressionb, n (%) | – | 46 (85) | – |
IHDS score | 10 (10–11) | 11 (10–12) | < 0.001 |
IHDS ≤10, n (%) | 31 (57) | 17 (32) | < 0.001 |
MoCA score | 27 (26–29) | 27 (26–28) | 0.818 |
MoCA ≤25, n (%) | 13 (24) | 12 (22) | 1.000 |
MoCA ≤21, n (%) | 4 (7) | 4 (7) | 1.000 |